Last Updated on October 17, 2024 by The Health Master
New York: The U.S. Food and Drug Administration (USFDA) said it has authorized state-licensed pharmacists to prescribe Pfizer Inc’s COVID-19 pill to eligible patients to help improve access to the treatment.
The antiviral drug, Paxlovid, has been cleared for use and has been available for free in the United States since December, but fewer than half of the nearly 4 million courses distributed to pharmacies by the government so far have been administered.
Use of the pill, authorized to treat newly infected, at-risk people to prevent severe illness, has, however, jumped in recent weeks as infections rise.
“Since Paxlovid must be taken within five days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment for some patients,” Patrizia Cavazzoni, director for the USFDA’s Center for Drug Evaluation and Research, said in a statement.
The agency said patients who tested positive for COVID-19 should bring their health records for the pharmacists to review for kidney and liver problems.
The American Medical Association (AMA) said in a statement prescribing decisions should be made by a doctor wherever possible.
“It (Paxlovid) is not for everyone and prescribing it requires knowledge of a patient’s medical history, as well as clinical monitoring for side effects and follow-up care to determine whether a patient is improving,” said AMA President Jack Resneck.
The USFDA said pharmacists should refer patients to a healthcare professional licensed to prescribe drugs if there is insufficient information to assess kidney or liver function, or if modifications are needed due to a potential drug reaction.
Patients with reduced kidney function may need a lower dose of the treatment, the agency has said.
People in socially and economically disadvantaged regions are about half as likely to receive antiviral COVID-19 pills like Paxlovid than those in wealthier zip codes, a study by the U.S. Centers for Disease Control and Prevention showed.
Schedule K: Govt issues final notification on certain conditions for Liquid Antiseptics
Drones to deliver blood, medicines with controlled temperature
USFDA gives nod for Triamcinolone Acetonide injectable suspension
USFDA issues 2 observations to Cipla Indore Plant
High Court issues notice on plea against Online sale of Medicines
NPPA extends trade margin capping on 5 Medical Devices
2 Doctors suspended for favouring Pharma Company
NPPA fixes retail prices of 84 drug formulations
9th edition of IP released containing 3,152 Monographs
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
